Results 71 to 80 of about 49,264 (163)
Cardiovascular Health in Women—Across the Lifespan
Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar +5 more
wiley +1 more source
Prenatal Diagnosis, Volume 46, Issue 4, Page 581-588, April 2026.ABSTRACT Noonan syndrome (NS) is a rare multisystemic condition among the RASopathy group, characterized by a broad phenotypic spectrum and genetic variability. It results from pathogenic variants in genes regulating the RAS/MAPK pathway, affecting cell proliferation and differentiation.
Romain Martineau +10 more
wiley +1 more source
Models of the human heart for biomedical research: Opportunities and challenges
Physiological Reports, Volume 14, Issue 7, April 2026.This manuscript reviews models that can be used to study the physiology and pathophysiology of the heart, and describes some the limitaions and ethical concerns associated with the use of human tissue. Abstract Model systems that mimic human cardiac structure and function are essential for the development of novel diagnostics and effective treatments ...
Katrin Streckfuss‐Bömeke +21 more
wiley +1 more source
, 2022 Introduction and ObjectivesThe risk of ventricular arrhythmia and heart failure in patients with hypertrophic obstructive cardiomyopathy (HOCM) is much higher than that in the general population.
Jilin Zheng (4029908) +8 more
core +1 more source
Clinical Cardiology, Volume 49, Issue 3, March 2026.In Asian patients with hypertrophic cardiomyopathy, integrating NT‐proBNP with the clinical HCM‐AF score provides significant incremental prognostic value. This combined multiparametric assessment enhances the predictive accuracy for new‐onset atrial fibrillation, enabling more precise risk stratification and targeted clinical management.
Yi‐Peng Gao +10 more
wiley +1 more source
, 2017 Background:NT-proBNP level is a predictive factor in hypertrophic cardiomyopathy patients, in which left ventricular outflow tract obstruction contributes to an increased NT-proBNP level.
Shuiyun Wang +9 more
core +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground Septal myectomy and alcohol septal ablation (ASA) are septal reduction therapies for patients with symptomatic obstructive hypertrophic cardiomyopathy.
Nirav Patel +10 more
doaj +1 more source
Journal of Magnetic Resonance Imaging, Volume 63, Issue 3, Page 859-871, March 2026.ABSTRACT Background A detailed evaluation of hemodynamics, supportive morphology, and deformation may help uncover the pathophysiology of hypertrophic obstructive cardiomyopathy (HOCM) and the changes wrought by alcohol septal ablation (ASA). Purpose To investigate the global cardiac volume, myocardial deformation, and hemodynamic characteristics ...
Kenichiro Suwa +5 more
wiley +1 more source
, 2022 Introduction and ObjectivesThe risk of ventricular arrhythmia and heart failure in patients with hypertrophic obstructive cardiomyopathy (HOCM) is much higher than that in the general population.
Jilin Zheng (4029908) +8 more
core +1 more source
, 2013 In patients with hypertrophic obstructive cardiomyopathy, hemodynamically significant ventricular septal defect after septal myectomy is a rare sequela that warrants closure. Percutaneous closure provides a safer alternative to repeated sternotomy, which
Singh, Vikas +5 more
core +1 more source